FDAnews
www.fdanews.com/articles/81157-bausch-lomb-completes-acquisition-of-shandong-chia-tai-freda-pharmaceutical-group

BAUSCH & LOMB COMPLETES ACQUISITION OF SHANDONG CHIA TAI FREDA PHARMACEUTICAL GROUP

September 26, 2005

Bausch & Lomb (NYSE:BOL) has completed the previously announced acquisition of a controlling interest in Shandong Chia Tai Freda Pharmaceutical Group (CTF), the leading ophthalmic pharmaceutical company in China, from Sino Biopharmaceutical Ltd.(HKSE: 1177.HK) for $200 million in cash. The acquisition will accelerate Bausch & Lomb's expansion into the rapidly growing ophthalmic pharmaceuticals market in China and provide Bausch & Lomb with a national pharmaceuticals sales and distribution network, strong domestic brands, a GMP-certified manufacturing facility, and expertise in regulatory affairs and product development.

Finanzen.net (http://finanzen.net/news/news_detail.asp?NewsNr=337472)